Zim Laboratories Ltd vs Zydus Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Zim Laboratories Ltd is ₹ 96 as of 18 May 15:30 . The P/E Ratio of Zim Laboratories Ltd changed from 16.1 on March 2021 to 32.1 on March 2025 . This represents a CAGR of 14.80% over 5 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 21.1 on March 2021 to 19.7 on March 2025 . This represents a CAGR of -1.36% over 5 years The Market Cap of Zim Laboratories Ltd changed from ₹ 117.75 crore on March 2021 to ₹ 390.78 crore on March 2025 . This represents a CAGR of 27.11% over 5 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 45131 crore on March 2021 to ₹ 89122 crore on March 2025 . This represents a CAGR of 14.58% over 5 years The revenue of Zim Laboratories Ltd for the Dec '25 is ₹ 110.36 crore as compare to the Sep '25 revenue of ₹ 90.75 crore. This represent the growth of 21.61% The revenue of Zydus Lifesciences Ltd for the Dec '25 is ₹ 6975 crore as compare to the Sep '25 revenue of ₹ 6232 crore. This represent the growth of 11.93% The ebitda of Zim Laboratories Ltd for the Dec '25 is ₹ 14.51 crore as compare to the Sep '25 ebitda of ₹ 7.8 crore. This represent the growth of 86.03% The ebitda of Zydus Lifesciences Ltd for the Dec '25 is ₹ 1842 crore as compare to the Sep '25 ebitda of ₹ 2090 crore. This represent the decline of -11.85% The net profit of Zim Laboratories Ltd changed from ₹ 0.9 crore to ₹ 4.4 crore over 7 quarters. This represents a CAGR of 147.65% The net profit of Zydus Lifesciences Ltd changed from ₹ 1463 crore to ₹ 965.1 crore over 7 quarters. This represents a CAGR of -21.18% The Dividend Payout of Zim Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 24.28 % on March 2021 to 19.16 % on March 2025 . This represents a CAGR of -4.63% over 5 years .

About Zim Laboratories Ltd

Zim Laboratories Limited was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in Maharashtra.
The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Mumbai.
The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India.
The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector. During the year 2019-20, ZIM Health Technologies Limited was acquired, making it a wholly owned subsidiary of the Company.
SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.

About Zydus Lifesciences Ltd

Zydus Lifesciences Limited, initially known as Cadila Healthcare Limited was incorporated in May, 1995, which changed to Zydus Lifesciences Limited on February 24, 2022.
The Company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. The Company's operation includes pharmaceuticals, which includes human formulations, veterinary formulations and bulk durgs, diagnostics, herbal products, skin care products and OTC products.

FAQs for the comparison of Zim Laboratories Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Zim Laboratories Ltd or Zydus Lifesciences Ltd?

Market cap of Zim Laboratories Ltd is 514 Cr while Market cap of Zydus Lifesciences Ltd is 99,737 Cr

What are the key factors driving the stock performance of Zim Laboratories Ltd and Zydus Lifesciences Ltd?

The stock performance of Zim Laboratories Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Zim Laboratories Ltd and Zydus Lifesciences Ltd?

As of May 18, 2026, the Zim Laboratories Ltd stock price is INR ₹96.0. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹991.2.

How do dividend payouts of Zim Laboratories Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Zim Laboratories Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.